# APTN (Adaptin Bio, Inc.) - SEC EDGAR Financial Statements

> Adaptin Bio, Inc. reported $1.09M in total assets and a net loss of $4.68M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/APTN
- Markdown: https://convexityos.com/fundamentals/APTN.md
- SEC CIK: 0001938571
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001938571&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$4.67M | Operating profit |
| Net Income | FY 2025 | -$4.68M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.51 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $430K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Research & Development | $1.77M | $1.82M | -- |
| Total Operating Expenses | $5.41M | $2.57M | -- |
| **Operating Income** | -$5.41M | -$2.57M | -$86K |
| Interest Expense | $73K | $341K | -- |
| Income Before Tax | -$5.17M | -$3.12M | -- |
| **Net Income** | -$5.17M | -$3.12M | -$86K |
| Basic EPS | -$0.66 | -$0.96 | -$0.02 |
| **Diluted EPS** | -$0.66 | -$0.96 | -$0.02 |
| Basic Shares Outstanding | 7.8M | 3.2M | 5.0M |
| Diluted Shares Outstanding | 7.8M | 3.2M | 5.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $116K | $138K | $166K | $593K | $779K | $340K | $62K | $258K |
| Total Operating Expenses | $954K | $1.20M | $1.14M | $1.37M | $1.68M | $1.52M | $850K | $508K |
| **Operating Income** | -$954K | -$1.20M | -$1.14M | -$1.37M | -$1.68M | -$1.52M | -$850K | -$508K |
| Interest Expense | $3.0K | $4.7K | $1.9K | $0 | $0 | $0 | $73K | $146K |
| Income Before Tax | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| **Net Income** | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| Basic EPS | -$0.10 | -$0.14 | -$0.13 | -- | -$0.20 | -$0.18 | -$0.10 | -- |
| **Diluted EPS** | -$0.10 | -$0.14 | $0.13 | -- | -$0.20 | -$0.18 | $0.10 | -- |
| Basic Shares Outstanding | 9.2M | 8.8M | 8.7M | -- | 8.5M | 8.5M | 5.8M | -- |
| Diluted Shares Outstanding | 9.2M | 8.8M | 8.7M | -- | 8.5M | 8.5M | 5.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $459K | $34K | $380 | $500 |
| **Cash & Short-Term Investments** | $459K | $34K | $380 | $500 |
| **Total Current Assets** | $619K | $46K | $380 | $500 |
| **Total Non-Current Assets** | $0 | $194K | $0 | $0 |
| **Total Assets** | $619K | $239K | $380 | $500 |
| Accounts Payable | $1.51M | $1.36M | -- | -- |
| **Total Current Liabilities** | $2.11M | $4.34M | $113K | $28K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.11M | $4.34M | $113K | $28K |
| Common Stock | $866 | $325 | $500 | $500 |
| Retained Earnings | -$9.29M | -$4.12M | -$113K | -$28K |
| **Total Stockholders' Equity** | -$1.49M | -$4.10M | -$978K | -$27K |
| Total Equity | -$1.49M | -$4.10M | -$978K | -$27K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $430K | $670K | $301K | $459K | $579K | $1.35M | $2.37M | $34K |
| **Cash & Short-Term Investments** | $430K | $670K | $301K | $459K | $579K | $1.35M | $2.37M | $34K |
| **Total Current Assets** | $1.09M | $981K | $706K | $619K | $979K | $1.66M | $2.85M | $46K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $194K |
| **Total Assets** | $1.09M | $981K | $706K | $619K | $979K | $1.66M | $2.85M | $239K |
| Accounts Payable | $1.69M | $1.67M | $1.37M | $1.51M | $1.34M | $667K | $327K | $1.36M |
| **Total Current Liabilities** | $2.76M | $2.65M | $2.48M | $2.11M | $1.86M | $1.19M | $1.11M | $4.34M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $2.76M | $2.65M | $2.48M | $2.11M | $1.86M | $1.19M | $1.11M | $4.34M |
| Common Stock | $926 | $905 | $879 | $866 | $846 | $846 | $840 | $325 |
| Retained Earnings | -$12.60M | -$11.64M | -$10.44M | -$9.29M | -$7.92M | -$6.25M | -$4.73M | -$4.12M |
| **Total Stockholders' Equity** | -$1.67M | -$1.67M | -$1.78M | -$1.49M | -$881K | $474K | $1.75M | -$4.10M |
| Total Equity | -$1.67M | -$1.67M | -$1.78M | -$1.49M | -$881K | $474K | $1.75M | -$4.10M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$5.17M | -$3.12M | -$86K |
| Stock-Based Compensation | $497K | -- | -- |
| Change in Payables | $497K | $1.08M | -- |
| **Operating Cash Flow** | -$4.78M | -$649K | -$81K |
| **Financing Cash Flow** | $5.20M | $679K | $81K |
| **Net Change in Cash** | $425K | $29K | -$120 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$957K | -$1.21M | -$1.15M | -$1.37M | -$1.68M | -$1.52M | -$603K | -$857K |
| Stock-Based Compensation | $184K | $194K | $345K | -- | $320K | -- | -- | -- |
| Change in Payables | $42K | $260K | -$141K | $174K | $672K | $340K | -$688K | $430K |
| **Operating Cash Flow** | -$965K | -$450K | -$596K | -$703K | -$772K | -$1.02M | -$2.28M | $113K |
| Common Stock Issued | $0 | $260K | $652K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $724K | $819K | $438K | $583K | $0 | $0 | $4.62M | -$194K |
| **Net Change in Cash** | -$240K | $369K | -$158K | -$120K | -$772K | -$1.02M | $2.34M | -$81K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Assets (ROA) | -834.6% | -1304.2% | -22524.5% |
| Current Ratio | 0.29x | 0.01x | 0.00x |
| Quick Ratio | 0.22x | 0.01x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -861.8% | -194.0% | -- |
| Return on Assets (ROA) | -430.0% | -549.7% | -808.7% | -834.6% | -475.4% | -245.9% | -118.6% | -1304.2% |
| Current Ratio | 0.39x | 0.37x | 0.28x | 0.29x | 0.53x | 1.40x | 2.57x | 0.01x |
| Quick Ratio | 0.16x | 0.25x | 0.12x | 0.22x | 0.31x | 1.14x | 2.14x | 0.01x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -723.9% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
